SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2023-05-10 12:23
Tx date 2023-05-08
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+500,000 vol
1,155,000
Filed 2023-03-14 18:14
Tx date 2023-03-14
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
$404,250
+2,021,250 vol
$0.20 each
6,744,776
Filed 2023-03-14 18:13
Tx date 2023-03-14
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$404,250
+4,042,500 vol
$0.10 each
17,401,616
Filed 2023-02-01 19:04
Tx date 2023-02-01
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$12,249
+116,666 vol
$0.105 each
13,359,116
Filed 2023-01-26 18:02
Tx date 2023-01-26
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+300,000 vol
655,000
Filed 2023-01-19 16:53
Tx date 2023-01-17
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$84,923
+943,596 vol
$0.09 each
13,242,450
Filed 2023-01-03 12:14
Tx date 2022-12-30
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$621,925
+6,219,250 vol
$0.10 each
12,298,854
Filed 2023-01-03 12:13
Tx date 2022-12-30
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption

+3,109,625 vol
4,723,526
Filed 2023-01-03 12:10
Tx date 2022-12-30
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$621,925
+6,219,250 vol
$0.10 each
Filed 2022-05-27 22:22
Tx date 2022-05-04
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption

+1,051,151 vol
1,613,901
Filed 2022-05-27 22:21
Tx date 2022-05-04
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$378,414
+2,102,303 vol
$0.18 each
6,079,604
Filed 2021-06-17 11:50
Tx date 2021-06-15
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$130,000
+325,000 vol
$0.40 each
355,000
Filed 2021-06-07 18:02
Tx date 2021-06-02
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
$83,426
+216,693 vol
$0.385 each
3,977,301
Filed 2021-05-21 22:17
Tx date 2021-05-17
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$5,226
+29,037 vol
$0.18 each
3,760,608
Filed 2020-08-21 11:50
Tx date 2020-08-18
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$128,644
+714,693 vol
$0.18 each
3,731,571
Filed 2020-07-30 10:53
Tx date 2020-07-15
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
$202,590
+562,750 vol
$0.36 each
562,750
Filed 2020-07-30 10:52
Tx date 2018-12-14
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2020-07-30 10:52
Tx date 2020-07-15
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$202,590
+1,125,500 vol
$0.18 each
3,016,878
Filed 2019-11-22 16:50
Tx date 2019-11-04
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Common Shares
97 - Other
$166,869
+595,963 vol
$0.28 each
1,891,378
Filed 2019-09-24 12:06
Tx date 2019-09-10
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Convertible Preferred Shares Class A Preference Shares
16 - Acquisition or disposition under a prospectus exemption
$100,000
+250,000 vol
$0.40 each
250,000
Filed 2019-09-24 12:05
Tx date 2018-12-14
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Convertible Preferred Shares Class A Preference Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-12-18
Tx date 2018-12-14
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
30,000
Filed 2018-12-18
Tx date 2018-12-14
$RP
RepliCel Life Sciences Inc.
Schutte, Andrew
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
1,295,415